Back
78· Active
Health & Science18h 3m ago
The FDA granted expanded traditional approval to Elevidys, the first gene therapy for pediatric patients with Duchenne muscular dystrophy (DMD).
Silver Spring, Maryland, USA
Who
U.S. Food and Drug Administration (FDA) / Sarepta Therapeutics
What
The FDA granted expanded traditional approval to Elevidys, the first gene therapy for pediatric patients with Duchenne muscular dystrophy (DMD).
When
Mon, 08 Jun 2026 16:00:06 GMT · 18h 3m ago
Where
Silver Spring, Maryland, USA · 39.0228°N, 77.0318°W
Why
Clinical trial data demonstrated that the therapy significantly increases the expression of micro-dystrophin, likely predicting clinical benefit in patients aged 4 and older.
The Frontline Impact
How this affects you
This provides a critical treatment option for families dealing with a degenerative genetic disorder, potentially slowing or halting muscle loss in thousands of children globally.
Story chain
1 event in this threadNo related history yet — this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.